Gaku Hamami

548 total citations
26 papers, 418 citations indexed

About

Gaku Hamami is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gaku Hamami has authored 26 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Gaku Hamami's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Renal cell carcinoma treatment (5 papers). Gaku Hamami is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Renal cell carcinoma treatment (5 papers). Gaku Hamami collaborates with scholars based in Japan and United States. Gaku Hamami's co-authors include Sadao Kamidono, Soichi Arakawa, Osamu Matsumoto, Shuji Isotani, S Nagano, Masato Fujisawa, Yasuji Ichikawa, Kunihiko Yoshiya, Akihiro Higuchi and Kazumoto Iijima and has published in prestigious journals such as The Journal of Urology, Urology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Gaku Hamami

26 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaku Hamami Japan 10 156 121 108 86 80 26 418
Amir Belson United States 9 113 0.7× 108 0.9× 101 0.9× 263 3.1× 53 0.7× 21 523
A Jeantet Italy 11 95 0.6× 131 1.1× 254 2.4× 28 0.3× 74 0.9× 56 459
L. Dias Portugal 12 118 0.8× 137 1.1× 91 0.8× 215 2.5× 61 0.8× 36 388
N. Simforoosh Iran 13 106 0.7× 134 1.1× 34 0.3× 125 1.5× 77 1.0× 30 361
Robert P. Hudson United States 8 71 0.5× 175 1.4× 68 0.6× 224 2.6× 33 0.4× 22 465
L. Dias Portugal 14 206 1.3× 193 1.6× 81 0.8× 280 3.3× 60 0.8× 43 473
Frank J. Leary United States 15 128 0.8× 315 2.6× 24 0.2× 68 0.8× 210 2.6× 34 657
Ali Al Khader Jordan 11 61 0.4× 57 0.5× 73 0.7× 20 0.2× 98 1.2× 49 332
Susanna M. Nazarian United States 9 113 0.7× 105 0.9× 37 0.3× 166 1.9× 44 0.6× 19 302
A. Firouzan Iran 12 133 0.9× 100 0.8× 45 0.4× 162 1.9× 54 0.7× 21 357

Countries citing papers authored by Gaku Hamami

Since Specialization
Citations

This map shows the geographic impact of Gaku Hamami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaku Hamami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaku Hamami more than expected).

Fields of papers citing papers by Gaku Hamami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaku Hamami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaku Hamami. The network helps show where Gaku Hamami may publish in the future.

Co-authorship network of co-authors of Gaku Hamami

This figure shows the co-authorship network connecting the top 25 collaborators of Gaku Hamami. A scholar is included among the top collaborators of Gaku Hamami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaku Hamami. Gaku Hamami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaneko, Naoki, Akinobu Gotoh, Noboru Okamura, et al.. (2012). Potential tumor markers of renal cell carcinoma: α‐Enolase for postoperative follow up, and galectin‐1 and galectin‐3 for primary detection. International Journal of Urology. 20(5). 530–535. 28 indexed citations
2.
Tachibana, Mitsuhiro, et al.. (2004). [Cutaneous epithelioid granulomas caused by subcutaneous infusion of leuprorelin acetate: a case report].. PubMed. 50(3). 199–202. 7 indexed citations
3.
Fujisawa, M., Kazumoto Iijima, Takeshi Ishimura, et al.. (2002). Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatric Nephrology. 17(3). 165–168. 29 indexed citations
4.
Isotani, Shuji, Masato Fujisawa, Yasuji Ichikawa, et al.. (2002). Quality of life of living kidney donors: the short-form 36-item health questionnaire survey. Urology. 60(4). 588–592. 80 indexed citations
5.
Fujisawa, Masato, Yasuji Ichikawa, Kunihiko Yoshiya, et al.. (2000). Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology. 56(2). 201–206. 155 indexed citations
6.
Eto, Hiroshi, Koichi Ueno, Koji Yoshimura, et al.. (1994). Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Cancer Chemotherapy and Pharmacology. 35(S1). S46–S51. 14 indexed citations
7.
Gohji, Kazuo, Soichi Arakawa, Osamu Matsumoto, et al.. (1990). PREOPERATIVE ADJUVANT THERAPY FOR URINARY BLADDER CANCER. The Japanese Journal of Urology. 81(9). 1404–1411. 2 indexed citations
8.
Gohji, Kazuo, Atsushi Takenaka, Isao Hara, et al.. (1989). CLINICAL EVALUATION OF M-VAC CHEMOTHERAPY (METHOTREXATE, VINBLASTINE, ADREAMYCIN AND CISPLATIN) FOR ADVANCED UROTHLIAL CANCER. The Japanese Journal of Urology. 80(3). 321–328. 2 indexed citations
9.
Gohji, Kazuo, Hirokazu Yasuno, O. Matsumoto, et al.. (1989). [Clinical analysis of renal cell carcinoma with extension into the inferior vena cava].. PubMed. 24(6). 1266–76. 1 indexed citations
10.
Ogawa, Takeshi, Miki Sugimoto, Gaku Hamami, & Sadao Kamidono. (1989). [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].. PubMed. 35(1). 13–25. 1 indexed citations
11.
ISHIKAWA, Jiro, Ryuichiro Nishimura, Sakan Maeda, et al.. (1988). PRIMARY CHORIOCARCINOMA OF THE URINARY BLADDER. Acta Pathologica Japonica. 38(1). 113–120. 19 indexed citations
12.
Gohji, Kazuo, Gaku Hamami, & Sadao Kamidono. (1987). [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].. PubMed. 33(3). 329–35. 1 indexed citations
13.
Harada, Kenji, Shinichi Morishita, Hitoshi Nagata, et al.. (1987). Clinical Evaluation of Basic Fetoprotein in Testicular Cancer. The Journal of Urology. 138(5). 1178–1180. 4 indexed citations
14.
Arakawa, Soichi, et al.. (1987). Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 113(1). 95–98. 19 indexed citations
15.
Oka, Nobuo, et al.. (1986). [A case of prostatic leiomyosarcoma].. PubMed. 32(3). 462–7. 2 indexed citations
16.
Gohji, Kazuo, Tsuneyoshi Ogawa, Masakazu Sugino, et al.. (1986). [A case of pure choriocarcinoma of the testis in an elderly man].. PubMed. 32(9). 1298–302. 1 indexed citations
17.
Gohji, Kazuo, et al.. (1985). [Comparative study of chemosensitivity tests of human urogenital tumors between a clonogenic assay and a novel dye exclusion test].. PubMed. 12(6). 1294–300. 2 indexed citations
18.
Kamidono, Sadao, et al.. (1985). Urinary Diversion: Anastomosis of the Ureters into a Sigmoid Pouch and End-to-Side Sigmoidorectostomy. The Journal of Urology. 133(3). 391–394. 9 indexed citations
19.
Kamidono, Sadao, et al.. (1984). New Preoperative Chemotherapy for Bladder Cancer Using Combination Hemodialysis and Direct Hemoperfusion: Preliminary Report. The Journal of Urology. 131(1). 36–40. 7 indexed citations
20.
Hamami, Gaku, et al.. (1981). A fundamental study of regional chemotherapy given by intraarterial infusion with concomitant hemodialysis and hemoperfusion.. PubMed. 19(3). 176–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026